Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.

Rasmussen AL, Tchitchek N, Susnow NJ, Krasnoselsky AL, Diamond DL, Yeh MM, Proll SC, Korth MJ, Walters KA, Lederer S, Larson AM, Carithers RL, Benecke A, Katze MG.

Hepatology. 2012 Jul;56(1):17-27. doi: 10.1002/hep.25612. Epub 2012 Jun 5.

2.

Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.

Watt KD, Lyden ER, Gulizia JM, McCashland TM.

Liver Transpl. 2006 Jan;12(1):134-9.

3.

To transplant or not to transplant recurrent hepatitis C and liver failure.

Forman LM.

Clin Liver Dis. 2003 Aug;7(3):615-29. Review.

PMID:
14509530
4.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

5.

Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.

Howell J, Sawhney R, Angus P, Fink M, Jones R, Wang BZ, Visvanathan K, Crowley P, Gow P.

Transpl Infect Dis. 2013 Dec;15(6):588-99. doi: 10.1111/tid.12134. Epub 2013 Sep 13.

PMID:
24028328
6.

Kinetics of hepatitis C virus reinfection after liver transplantation.

Powers KA, Ribeiro RM, Patel K, Pianko S, Nyberg L, Pockros P, Conrad AJ, McHutchison J, Perelson AS.

Liver Transpl. 2006 Feb;12(2):207-16.

7.

Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation.

López-Labrador FX, Bracho MA, Berenguer M, Coscollà M, Rayón JM, Prieto M, Carrasco D, Gómez MD, Moya A, González-Candelas F.

J Viral Hepat. 2006 Feb;13(2):104-15.

PMID:
16436128
8.

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.

Joshi D, Salehi S, Brereton H, Arno M, Quaglia A, Heaton N, O'Grady J, Agarwal K, Aluvihare V.

Liver Transpl. 2013 Apr;19(4):383-94. doi: 10.1002/lt.23613. Epub 2013 Mar 22.

9.

Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.

Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.

Transplantation. 2007 Aug 15;84(3):331-9.

PMID:
17700157
10.
11.

Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C.

Rayhill SC, Kirby PA, Voigt MD, La Brecque DR, Lutz CT, Katz DA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Heisey D, Wu YM, Schmidt WN.

Transplantation. 2005 Aug 27;80(4):448-56.

PMID:
16123717
12.

Hepatitis C virus and liver transplantation.

Ahmed A, Keeffe EB.

Clin Liver Dis. 2001 Nov;5(4):1073-90. Review.

PMID:
11685796
13.

Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.

Diamond DL, Krasnoselsky AL, Burnum KE, Monroe ME, Webb-Robertson BJ, McDermott JE, Yeh MM, Dzib JF, Susnow N, Strom S, Proll SC, Belisle SE, Purdy DE, Rasmussen AL, Walters KA, Jacobs JM, Gritsenko MA, Camp DG, Bhattacharya R, Perkins JD, Carithers RL Jr, Liou IW, Larson AM, Benecke A, Waters KM, Smith RD, Katze MG.

Hepatology. 2012 Jul;56(1):28-38. doi: 10.1002/hep.25649. Epub 2012 Apr 24.

14.

Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life.

Feurer ID, Wright JK, Payne JL, Kain AC, Wise PE, Hale P, Chapman WC, Speroff T, Pinson CW.

J Gastrointest Surg. 2002 Jan-Feb;6(1):108-15.

PMID:
11986026
15.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.

Minisini R, Giarda P, Grossi G, Bitetto D, Toniutto P, Falleti E, Avellini C, Occhino G, Fabris C, Pirisi M.

J Gastroenterol. 2011 Nov;46(11):1307-15. doi: 10.1007/s00535-011-0440-8. Epub 2011 Jul 23.

PMID:
21789480
16.

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.

Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.

Liver Transpl. 2004 Oct;10(10):1248-55.

17.

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.

Liver Transpl. 2009 Dec;15(12):1872-81. doi: 10.1002/lt.21954.

18.

Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.

Eurich D, Bahra M, Boas-Knoop S, Lock JF, Golembus J, Neuhaus R, Neuhaus P, Neumann UP.

Liver Transpl. 2011 Mar;17(3):279-88. doi: 10.1002/lt.22190.

19.

Perioperative viral kinetics: new insights or the Emperor's new clothes?

Charlton M.

Liver Transpl. 2006 Feb;12(2):194-5. No abstract available.

20.

Hepatitis C virus in the transplant setting.

Berenguer M, Wright TL.

Antivir Ther. 1998;3(Suppl 3):125-36. Review.

PMID:
10726062
Items per page

Supplemental Content

Write to the Help Desk